Evidence map›Paper›PMID 21106692›Full record

ArticleAmerican journal of physiology. Cell physiology2011

Somatostatin stimulates intestinal NHE8 expression via p38 MAPK pathway.

Chunhui Wang, Hua Xu, Huacong Chen, Jing Li, Bo Zhang, Chengwei Tang, Fayez K Ghishan

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03012594 (A Pilot Study to Evaluate Safety and Effectiveness of Lanreotide in the Treatment of Patients With Small Bowel Motility Disorders), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03012594 phase2completednot on this mapstarted 2017, after this paper: background citation

A Pilot Study to Evaluate Safety and Effectiveness of Lanreotide in the Treatment of Patients With Small Bowel Motility Disorders (SBMD): a Prospective, Non-randomized, Single-center Study of 20 Participants

TypeinterventionalSponsorNorthwell HealthRan2017 to 2019Enrolled12ConditionsGastrointestinal Motility Disorder, Intestinal DiseaseArmsLanreotide
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. The Physiological Function and Potential Role of the Ubiquitous NaInternational journal of molecular sciences · 2022
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Up-regulation of NHE8 by somatostatin ameliorates the diarrhea symptom in infectious colitis mice model.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2018
    Article
  9. Review
  10. Article
  11. Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  12. Intestinal NHE8 is highly expressed in goblet cells and its expression is subject to TNF-α regulation.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  13. Article
  14. Article
  15. Somatostatin regulates tight junction proteins expression in colitis mice.International journal of clinical and experimental pathology · 2014
    Article
  16. Article
  17. NHE8 plays important roles in gastric mucosal protection.American journal of physiology. Gastrointestinal and liver physiology · 2013
    Article
  18. Small intestinal ion transport.Current opinion in gastroenterology · 2012
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Chunhui WangDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Hua Xu
Huacong Chen
Jing Li
Bo Zhang
Chengwei Tang
Fayez K Ghishan
Arizona Science Center · USSichuan University · CNUniversity of Arizona · US

Funding

Regulation of a Novel Intestinal NHE Isoform (NHE8)R01DK073638 · NIDDK · UNIVERSITY OF ARIZONA · PI GHISHAN, FAYEZ KHALAF · 2006 to 2015
$3.1M
NIDDK NIH HHS R01 DK073638NIDDK NIH HHS R01-DK073638
6 · The paper itself

Abstract

Diarrhea is a common manifestation of gastrointestinal disorders. Diarrhea-induced losses of fluid and electrolyte could lead to dehydration and electrolyte imbalances, resulting in significant morbidity and mortality, especially in children living in developing countries. Somatostatin, a peptide hormone secreted by D-cells, plays an important role in regulating motility and intestinal Na(+) absorption. Although octreotide, a somatostatin analog, is used to treat diarrhea, its mechanisms of action are unclear. Here we showed that octreotide increased brush-border membrane Na(+)/H(+) exchanger 8 (NHE8) expression in the small intestine to the exclusion of other NHEs that participate in Na(+) absorption. The same effect also occurred in human intestinal cells (Caco-2). We found that the increase of NHE8 expression by somatostatin required p38 mitogen-activated protein kinase (MAPK) activation. Furthermore, the somatostatin receptor SSTR2 antagonist CYN154806 could abolish somatostatin-induced NHE8 expression and p38 MAPK phosphorylation. Thus our data provided the first concrete evidence indicating that somatostatin stimulates intestinal Na(+) absorption by increasing intestinal NHE8 expression through the SSTR2-p38 MAPK pathway.

Indexed as

AnimalsAntidiarrhealsCaco-2 CellsCell LineFemaleHumansIntestinal AbsorptionIntestine, SmallMiceMicrovilliOctreotideOligopeptidesp38 Mitogen-Activated Protein KinasesPhosphorylationReceptors, SomatostatinSodiumAntidiarrhealsCYN 154806OctreotideOligopeptidesp38 Mitogen-Activated Protein KinasesReceptors, SomatostatinSLC9A8 protein, humanSlc9a8 protein, mouseSodiumSodium-Hydrogen ExchangersSomatostatinsomatostatin receptor 2

Identifiers

PMID21106692
PMCPMC3043635
OpenAlexW2097717640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.